USP8 and non-small cell lung carcinoma: The increased abundance of PD-L1 could weaken the immune response of immune system, and PD-L1 has been reported as a downstream deubiquitinating substrate of USP8 in pancreatic cancer [22] and non-small cell lung cancer [29].